Obesity Clinical Trial
Official title:
Effects of Environmental Temperature on Human White Adipose Tissue Thermogenic Capacity
Obesity is characterized by excessive white adipose tissue (WAT) that increases risk for disease. About 700 million adults are obese worldwide, designating the need of reducing excessive WAT in humans and subsequently the risk for disease. For this reason, previous research focused on the thermogenic capacity of white adipocytes in response to cold exposure. The investigators aimed to identify whether human WAT thermogenic activation could alter energy homeostasis and subsequently total body weight. The human WAT thermogenic capacity was assessed via Positron Emission Tomography/Computed Tomography (PET/CT) examination.
PET/CT cooling protocol Participants recruited through an advertisement in local newspapers
or by word of mouth. An initial appointment was made to inform participants about the study
and determine eligibility. A health pre-screening was done by interview through a suitable
medical history questionnaire. The investigators obtained written consent from 20 healthy (no
chronic disease and/or being under medication treatment) and non-smoking adult men [age:
36.30±5.33 (years); Body Mass Index: 28.46±5.49 (kg/m2)].
On the day of the measurements the participants advised to transport themselves by car to the
PET/CT Laboratory at 07:30 am, following at least a 12-hour fasting. At 8 am the participants
consumed a meal consisted of 50% carbohydrates, 20% proteins and 30% fat to avoid a thermic
effect of food on white adipose tissue (WAT) activity. Also, to avoid a thermic effect of
food on the Resting Energy Expenditure (REE) measurement, the caloric value of the meal was
15% of the total energy requirements of each participant. The total energy requirements was
calculated following previous methodology. At 14:00 pm participants underwent measurements
for body height using a Seca (Hamburg, Germany) stadiometer, body weight using a precision
scale (KERN & Sohn GmbH, Version 5.3, Germany) and Waist Hip Ratio using a tape measure. The
investigators also measured blood pressure using a Standard Aneroid sphygmomanometer
(Medisave, UK) according to standard guidelines. Blood glucose levels were determined via a
Contour NEXT/ASCENSIA monitor. Participants who displayed blood glucose >140 mg/dl and blood
pressure >140 mm/Hg were excluded from the study.
Immediately after the aforementioned measurements participants wore specific clothes
(long-sleeve sweatshirt and sweatpants) that offered 0.49 clo insulation. Participants then
undertook a REE assessment. Following the REE measurement participants remained in a sitting
position in a cold room at 16-17ºC (humidity ~30-40%) for two hours. The room temperature and
humidity were continuously monitored, while an investigator checked every 15 minutes
participants muscle shivering status, according to previous methodology. The muscle shivering
was tested using a scale, none (no tension of muscles reported), mild (slight muscle tonus in
masseter muscle), moderate (real shivering in proximal muscles), severe (uncontrolled
shivering in whole body). In case of moderate or severe shivering, participants were covered
with a blanket for the next 15 minutes. After the first hour of cold exposure an appropriate
dose - according to participants body weight - of F18 fludeoxyglucose (18F-FDG) was injected
to the participants.
Following the 2-hour cooling protocol participants undertook the PET/CT examination. A
Siemens Biograph 6 high resolution Erlangen Germany (2006) PET/CT was used to obtain images
from the top of the skull to the upper third of the thigh. Six to eight bed positions (five
minutes per bed position) were required.
White adipose tissue activity analysis WAT activity analysis (dorsolumbar region near
vertebrae L3 and abdominal region) was performed by two independent trained physicians.
REE assessments for PET/CT cooling protocol REE assessments were conducted between 14:00 to
15:00 pm to comply with guidelines regarding the thermic effect of food on REE. The
investigators have also instructed the participants to refrain from exercise, alcohol, and
passive smoking in 72-hour prior to the measurements. REE was measured using an automated
portable gas analyser (Oxycon Mobile, CareFusion, San Diego, USA) and the procedure was
identical to the REE assessment for our UCP1 studies described above.
Environmental temperature (Tenv) recording Environmental data (ambient temperature) were
obtained from Weather Underground (www.wunderground.com). Tenv was recording between January
2017 and March 2019. For the latter periods, the investigators obtained daily mean air
temperature from the closest weather station operated near the area participants lived; the
weather station Eleftherios Venizelos international station, Athens, Greece (37.93 °N, 23.93
°E) at an elevation of 94m.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |